The Fellows of the Academy of Immuno-Oncology (FAIO) are individuals who have made seminal contributions to move the field of cancer immunotherapy forward to the benefit of patients.
Along with name of nominee, nominator must provide one nomination letter (2 page limit) and the nominee’s CV. See more information including previous Fellows of the Academy of Immuno-Oncology here.
Established in 2005, the Richard V. Smalley Memorial Award and Lectureship is presented each year to a luminary in the field that has significantly contributed to the advancement of cancer immunotherapy research. It serves to honor those that have been pioneers in their work and made a notable impact worthy of high regard and recognition by their peers.
Recipient should be considered a “luminary” in the field and have significantly contributed to the advancement of cancer immunotherapy research. Society membership is not a requirement to receive this award.
Along with name of nominee, nominator must provide one nomination letter (2 page limit) and the nominee’s CV. See more information including previous winners of the Smalley Award here.
This nominated award recognizes an outstanding SITC member or collaborator who has made significant impact on SITC’s development and mission.
Nominator should supply one letter (2 page limit) and the nominee's CV. The nomination letter should address how the nominee impacted SITC's mission using the criteria listed.
Awarded to an individual or group who fosters and enhances the field through any of the following: increasing public understanding, awareness, research efforts and/or funding. This award is not intended to acknowledge an individual's or group's scientific contributions. Distinct from the SITC Lifetime Achievement Award, this award honors an individual's or group's effort in public service promoting cancer immunotherapy.
Candidates for the Tara Withington Public Service Award should have demonstrated outstanding leadership and accomplishment in meeting any of the following selection criteria:
Along with name of nominee(s), nominator must provide a brief description (2 page limit) that includes a description of the nominee's public service to the field of cancer immunotherapy. Please specifically comment on how the nominee(s) met one or more of the criteria listed.
This nominated award recognizes an individual who has made significant contributions and demonstrated outstanding commitment to the Journal for ImmunoTherapy of Cancer (JITC) — the official journal of the Society for Immunotherapy of Cancer.
Recipient has significantly contributed to the advancement of the journal and its aims through their distinguished record of service, leadership, and/or collaboration. Society membership is not a requirement to receive this award.
Along with name of nominee, nominator must provide a brief description (2 page limit) of their service to the Journal for ImmunoTherapy of Cancer (JITC).
2022Zelig Eshhar, PhDWeizmann Institute of Science Tel Aviv Sourasky Medical Center
2021Crystal L. Mackall, MDStanford University
2020Gordon Freeman, PhDDana-Farber Cancer Institute
2020Lieping Chen, MD, PhDYale School of Medicine
2020Arlene Sharpe, MD, PhDHarvard Medical School
2019Olivera J. Finn, PhDUniversity of Pittsburgh
2018Phillip D. Greenberg, MDFred Hutchinson Research Center
2017Paul Sondel, MD, PhDUniversity of Wisconsin-Madison
2016Suzanne L. Topalian, MDJohns Hopkins University School of Medicine Sidney Kimmel Comprehensive Cancer Center
2015Tasuku Honjo, MD, PhDKyoto University Graduate School of Medicine
2014Giorgio Trinchieri, MDNational Cancer Institute
2013Carl H. June, MDUniversity of Pennsylvania
2012Theresa L. Whiteside, PhDUniversity of Pittsburgh Cancer Institute
2011Ralph M. Steinman, MDThe Rockefeller University
2010James P. Allison, PhDMemorial Sloan-Kettering Cancer Center
2009Isaiah J. Fidler, DVM, PhDMD Anderson Cancer Center
2008Giorgio Parmiani, MDSan Raffaele Foundation
2007Ernest Borden, MDCleveland Clinic Foundation
2006Ronald Levy, MDStanford University School of Medicine
2005Steven A. Rosenberg, MD, PhDNational Cancer Institute, National Institutes of Health
2022Michael B. Atkins, MDGeorgetown Lombardi Comprehensive Cancer Center
2021Michael T. Lotze, MD, FACSUniversity of Pittsburgh
2022Bernard A. Fox, PhDEarle A. Chiles Research Institute, Providence Cancer Institute
2021Margaret Foti, PhD, MD (hc)American Association for Cancer Research
2020Jill O'Donnell-Tormey, PhDCancer Research Institute
2019Sean ParkerParker Institute for Cancer Immunotherapy
2022Cornelis J.M. Melief, MD, PhDLeiden University Medical Center & ISA Pharmaceuticals
2021James Gulley, MD, PhDNational Cancer Institute, National Institutes of Health
2020Pedro J. Romero, MDNovigenix
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com